Psychedelics for the management of symptoms of traumatic brain injury: Findings from the global psychedelic survey.
Prog Neuropsychopharmacol Biol Psychiatry January 30, 2026 DOI: 10.1016/j.pnpbp.2026.111624 via PubMed
Summary
AI-generated from the abstractPeople with traumatic brain injury who used psychedelics reported fewer symptoms of depression, anxiety, and post-traumatic stress than those who did not. The analysis of data from the Global Psychedelic Survey suggests that psychedelic use is associated with better mental health outcomes in this population, though the cross-sectional design cannot establish causation.
Study at a glance
| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 3,072 |
| Population | People with traumatic brain injury |
| Key finding | Psychedelic use is associated with lower levels of depression, anxiety, and PTSD symptoms among individuals with traumatic brain injury. |
Abstract
Psychedelics for the management of symptoms of traumatic brain injury: Findings from the global psychedelic survey.